Browsing Tag
Ginkgo Bioworks
6 posts
Ginkgo Bioworks (NYSE: DNA) wins $47m DOE contract to build AI-enabled cloud lab platform
Ginkgo Bioworks wins $47M PNNL contract to build modular AI-ready phenotyping platform. Find out how this move boosts its federal bioeconomy play.
Ginkgo Bioworks enhances NGS workflows by integrating Volta Labs’ Callisto Sample Prep System
Ginkgo Bioworks, a leader in synthetic biology and biosecurity, has integrated Volta Labs’ Callisto Sample Prep System into…
Ginkgo Bioworks acquires Proof Diagnostics to boost cell programming and biosecurity capabilities
Ginkgo Bioworks, a leader in cell programming and biosecurity, announced its acquisition of Proof Diagnostics, a trailblazer in…
Ginkgo Bioworks acquires Reverie Labs’ AI/ML assets to revolutionize biosecurity and drug discovery
In a strategic move to solidify its position as a leader in cell programming and biosecurity, Ginkgo Bioworks…
Ginkgo Bioworks to acquire fungal platform firm Dutch DNA Biotech
Ginkgo Bioworks has agreed to acquire Dutch DNA Biotech, a Netherlands-based company focused on developing fungal strains and…
US biotech company Ginkgo Bioworks to merge with Soaring Eagle in $15bn deal
Ginkgo Bioworks, a Boston-based biotech company, has agreed to merge with Soaring Eagle Acquisition Corp., a publicly traded…